Gorlin sign

From Food & Medicine Encyclopedia

Revision as of 02:41, 22 February 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Gorlin sign is a medical condition that is characterized by the ability of an individual to touch the tip of their nose with their tongue. This condition is named after Robert J. Gorlin, a geneticist and oral pathologist who first described it. Gorlin sign is often associated with Ehlers-Danlos syndrome, a group of disorders that affect connective tissues supporting the skin, bones, blood vessels, and many other organs and tissues.

Symptoms

The primary symptom of Gorlin sign is the ability to touch the tip of the nose with the tongue. This is due to an unusually long tongue (macroglossia) and/or a short upper lip. Other symptoms may include:

Causes

Gorlin sign is often associated with Ehlers-Danlos syndrome, particularly the hypermobility type. This is a genetic disorder that affects the body's connective tissues. Mutations in specific genes lead to abnormal collagen structure and function, leading to the symptoms seen in this condition.

Diagnosis

Diagnosis of Gorlin sign is primarily based on the physical examination. A detailed medical history is also important to identify any potential genetic disorders that may be associated with this condition. Genetic testing may be recommended in some cases.

Treatment

There is no specific treatment for Gorlin sign. Management is focused on treating the underlying condition, if present, and managing symptoms. Physical therapy may be recommended to help manage joint hypermobility and prevent injury.

See also

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.